insights from reprise iii, a significant step forward for tavi - europcr 2017
Published 7 years ago • 195 plays • Length 10:54Download video MP4
Download video MP3
Similar videos
-
3:10
reprise iii: a prospective randomised investigation of a novel tavi system - europcr 2017 hot line
-
4:41
perspectives from the reprise iii randomised trial - pcr london valves 2017
-
1:27:03
symetis acurate neo™ tf tavi system: unique self-expandable valve technology. europcr 2017
-
7:29
a new era in tavi - pcr london valves 2017
-
1:28:14
experience evolut r in complex cases - europcr 2017
-
59:49
planning for a long run: life-time management of bioprosthetic valve implantation - europcr 2021
-
59:28
the role of coronary interventionalist in tavi - from referral to timing of pci - europcr 2022
-
1:31:20
long-term valve performance for the next decade and beyond - europcr 2023
-
1:27:56
tavi in bicuspid aortic valve patients. sapien 3 platform a safe and efficient option - europcr 2021
-
54:59
double jeopardy: coronary disease in patients undergoing tavi - europcr 2022
-
6:38
evolving indications for tavi: a pcr statement – europcr 2019
-
58:21
optimising immediate and long-term outcomes after tavi - pcr london valves 2022
-
55:58
introducing navitor: a new tavi solution - europcr 2021
-
42:53
highlights of europcr 2015: interventional cardiovascular medicine
-
45:45
tavi lifetime management: tailoring treatment options to secure future possibilities - europcr 2023
-
1:28:52
remaining unmet needs and strategies in tavi - pcr london valves 2022
-
1:00:24
contemporary best clinical practice for tavi - europcr 2023
-
7:40
5 year predictions for tavi as a therapy for aortic stenosis - europcr 2023
-
0:20
altavalve: transcatheter mitral valve replacement (tmvr) #shorts #medical #animation